Home › Funds › NEOS Investment Management LLC › VRTX

NEOS Investment Management LLC position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

NEOS Investment Management LLC reported holding 217,010 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$113.5M, representing 0.36% of its reported portfolio and ranking #47 among its reported holdings. NEOS Investment Management LLC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)217.01K sh
Reported value held$113.45M
Portfolio Weight0.36%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How NEOS Investment Management LLC's VRTX position evolved

NEOS Investment Management LLC first disclosed a stake in VRTX in Q3 2023 at 11,117 shares (US$3.9M). The position peaked in Q3 2026 at 217,010 shares, worth US$113.5M. Across 13 filings, NEOS Investment Management LLC increased the stake 12 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 217,010 shares valued at US$113.5M — an increase of 23,704 shares quarter over quarter.. Notable position changes include a 66% increase in Q1 2024 (shares rose 12% over the following quarter), a 49% increase in Q2 2025 (shares fell 12% over the following quarter), a 49% increase in Q3 2025 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 11.12K $3.87M New
Q4 2023 14.40K $5.86M Add
Q1 2024 23.89K $9.99M Add
Q2 2024 29.98K $14.05M Add
Q3 2024 35.60K $16.56M Add
Q4 2024 43.33K $17.45M Add
Q1 2025 51.32K $24.88M Add
Q2 2025 76.24K $33.94M Add
Q3 2025 113.53K $44.46M Add
Q4 2025 146.20K $66.28M Add
Q1 2026 174.09K $77.74M Add
Q2 2026 193.31K $96.02M Add
Q3 2026 217.01K $113.45M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has NEOS Investment Management LLC held VRTX?

NEOS Investment Management LLC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is NEOS Investment Management LLC's current position in VRTX?

As of Q3 2026, NEOS Investment Management LLC holds 217.01K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $113.45M, representing 0.36% of its reported portfolio and ranking #47.

Has NEOS Investment Management LLC been buying or selling VRTX?

In the latest 13F filing (Q3 2026), NEOS Investment Management LLC increased its position in VRTX. The position peaked in Q3 2026 at 217.01K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.